Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Arch Biochem Biophys ; 569: 1-9, 2015 Mar 01.
Article in English | MEDLINE | ID: mdl-25659883

ABSTRACT

Sarcolemma damage and activation of various calcium channels are implicated in altered Ca(2+) homeostasis in muscle fibres of both Duchenne muscular dystrophy (DMD) sufferers and in the mdx mouse model of DMD. Previously we have demonstrated that also in mdx myoblasts extracellular nucleotides trigger elevated cytoplasmic Ca(2+) concentrations due to alterations of both ionotropic and metabotropic purinergic receptors. Here we extend these findings to show that the mdx mutation is associated with enhanced store-operated calcium entry (SOCE). Substantially increased rate of SOCE in mdx myoblasts in comparison to that in control cells correlated with significantly elevated STIM1 protein levels. These results reveal that mutation in the dystrophin-encoding Dmd gene may significantly impact cellular calcium response to metabotropic stimulation involving depletion of the intracellular calcium stores followed by activation of the store-operated calcium entry, as early as in undifferentiated myoblasts. These data are in agreement with the increasing number of reports showing that the dystrophic pathology resulting from dystrophin mutations may be developmentally regulated. Moreover, our results showing that aberrant responses to extracellular stimuli may contribute to DMD pathogenesis suggest that treatments inhibiting such responses might alter progression of this lethal disease.


Subject(s)
Calcium Channels/metabolism , Calcium Signaling , Muscular Dystrophy, Duchenne/metabolism , Myoblasts, Skeletal/metabolism , Adenosine Triphosphate/metabolism , Adenosine Triphosphate/pharmacology , Animals , Calcium Signaling/drug effects , Cell Line , Mice , Mice, Inbred C57BL , Mice, Inbred mdx , Muscular Dystrophy, Animal/genetics , Muscular Dystrophy, Animal/metabolism , Muscular Dystrophy, Duchenne/genetics , Myoblasts, Skeletal/drug effects , Stromal Interaction Molecule 1 , TRPC Cation Channels/metabolism , TRPC6 Cation Channel
2.
PLoS One ; 9(9): e108364, 2014.
Article in English | MEDLINE | ID: mdl-25260053

ABSTRACT

Duchenne muscular dystrophy (DMD) is a neuromuscular disease that arises from mutations in the dystrophin-encoding gene. Apart from muscle pathology, cognitive impairment, primarily of developmental origin, is also a significant component of the disorder. Convergent lines of evidence point to an important role for dystrophin in regulating the molecular machinery of central synapses. The clustering of neurotransmitter receptors at inhibitory synapses, thus impacting on synaptic transmission, is of particular significance. However, less is known about the role of dystrophin in influencing the precise expression patterns of proteins located within the pre- and postsynaptic elements of inhibitory synapses. To this end, we exploited molecular markers of inhibitory synapses, interneurons and dystrophin-deficient mouse models to explore the role of dystrophin in determining the stereotypical patterning of inhibitory connectivity within the cellular networks of the hippocampus CA1 region. In tissue from wild-type (WT) mice, immunoreactivity of neuroligin2 (NL2), an adhesion molecule expressed exclusively in postsynaptic elements of inhibitory synapses, and the vesicular GABA transporter (VGAT), a marker of GABAergic presynaptic elements, were predictably enriched in strata pyramidale and lacunosum moleculare. In acute contrast, NL2 and VGAT immunoreactivity was relatively evenly distributed across all CA1 layers in dystrophin-deficient mice. Similar changes were evident with the cannabinoid receptor 1, vesicular glutamate transporter 3, parvalbumin, somatostatin and the GABAA receptor alpha1 subunit. The data show that in the absence of dystrophin, there is a rearrangement of the molecular machinery, which underlies the precise spatio-temporal pattern of GABAergic synaptic transmission within the CA1 sub-field of the hippocampus.


Subject(s)
Cognition Disorders/metabolism , Dystrophin/genetics , Hippocampus/metabolism , Muscular Dystrophy, Duchenne/metabolism , Neural Inhibition/physiology , Synapses/metabolism , Animals , Cell Adhesion Molecules, Neuronal/metabolism , Cognition Disorders/etiology , Mice , Mice, Inbred mdx , Muscular Dystrophy, Duchenne/complications , Nerve Tissue Proteins/metabolism , Vesicular Inhibitory Amino Acid Transport Proteins/metabolism
3.
Postepy Biochem ; 60(4): 483-9, 2014.
Article in English | MEDLINE | ID: mdl-25807827

ABSTRACT

The P2 purinergic (nucleotide) receptor super-family comprises of two families of protein. The P2X, which are channel-forming ionotropic receptors and the P2Y metabotropic receptors activating G protein-mediated signalling pathways. Members of both groups have been identified in skeletal muscle cells at different stages of differentiation. It is well documented that sequential expression and down-regulation of particular P2 receptors on the surface of sarcolemma is closely associated with muscle maturation during embryogenesis and postnatal growth. P2 receptors are also involved in muscle regeneration following injury. Moreover, enhanced expression of specific purinergic receptors together with increased availability of extracellular ATP in dystrophic muscles are important elements of the dys- trophic pathophysiology considerably increasing severity.


Subject(s)
Adenosine Triphosphate/metabolism , Muscle, Skeletal/metabolism , Muscular Dystrophies/metabolism , Receptors, Purinergic P2/metabolism , Cell Differentiation , Down-Regulation , Humans , Muscle, Skeletal/embryology , Muscle, Skeletal/pathology , Muscular Dystrophies/pathology , Sarcolemma/metabolism , Signal Transduction/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...